Abstract |
Adenosine kinase inhibition is an attractive therapeutic approach for several conditions for example, neurodegeneration, seizures, ischemia, inflammation and pain. Several nucleosidic and non-nucleosidic inhibitors are available. Using a virtual screening approach, we have discovered that 2-aryl oxazolo- pyrimidines are adenosine kinase inhibitors. Subsequent high throughput derivatization enabled the optimization of this new inhibitor chemotype resulting in highly potent derivatives. A variety of analogues were produced by applying liquid phase parallel synthesis to vary the 7-amino residues as well as the 2-aryl moiety.
|
Authors | M Bauser, G Delapierre, M Hauswald, T Flessner, D D'Urso, A Hermann, B Beyreuther, J De Vry, P Spreyer, E Reissmüller, H Meier |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 14
Issue 8
Pg. 1997-2000
(Apr 19 2004)
ISSN: 0960-894X [Print] England |
PMID | 15050645
(Publication Type: Journal Article)
|
Chemical References |
- Enzyme Inhibitors
- Oxazoles
- Pyrimidines
- Adenosine Kinase
|
Topics |
- Adenosine Kinase
(antagonists & inhibitors, metabolism)
- Enzyme Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Molecular Structure
- Oxazoles
(chemical synthesis, chemistry)
- Pyrimidines
(chemical synthesis, pharmacology)
|